Fresenius Medical Ownership
| FMS Stock | USD 23.45 0.14 0.60% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Fresenius |
Fresenius Stock Ownership Analysis
The company has price-to-book (P/B) ratio of 0.96. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fresenius Medical Care has Price/Earnings To Growth (PEG) ratio of 0.48. The entity last dividend was issued on the 17th of May 2024. The firm had 2:1 split on the 4th of December 2012. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Fresenius Medical is traded on New York Stock Exchange in the United States. To learn more about Fresenius Medical Care call FACHE MBA at 49 6172 609 0 or check out https://www.freseniusmedicalcare.com.Fresenius Medical Outstanding Bonds
Fresenius Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Fresenius Medical Care uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Fresenius bonds can be classified according to their maturity, which is the date when Fresenius Medical Care has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| FRESLN 425 02 OCT 50 Corp BondUS358070AB61 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| FMEGR 375 15 JUN 29 Corp BondUS35805BAA61 | View | |
| FMEGR 2375 16 FEB 31 Corp BondUS35805BAB45 | View | |
| FMEGR 1875 01 DEC 26 Corp BondUS35805BAC28 | View | |
| FMEGR 3 01 DEC 31 Corp BondUS35805BAE83 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.